This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Eisai R&D Management Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jianjun Xiao: Inventor in Cancer Therapy
Introduction
Jianjun Xiao is an inventor based in Lexington, Massachusetts. His work includes a patented approach to cancer therapy involving an oral dosage form of an estrogen receptor-alpha inhibitor.
Latest Patents
Xiao is associated with 1 patent: “Method for Treating Cancer with an Oral Dosage Form of an Estrogen Receptor-Alpha Inhibitor.” The invention describes pharmaceutical compositions containing an inhibitor of human ERα and methods for using it in cancer therapy. It focuses on dosages of H3B-6545 with defined pharmacokinetic profiles intended to support effective and safe administration to patients.
Career Highlights
Xiao is associated with Eisai R&D Management Co., Ltd. His patent reflects work on developing and administering targeted therapies for cancer.
Collaborations
The provided information identifies Nathalie M. Rioux and Victoria Rimkunas as Xiao’s coworkers.
Conclusion
Jianjun Xiao’s patent concerns the dosing and use of an ERα inhibitor, highlighting a contribution to research into cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile